Literature DB >> 8432617

Endogenous and exogenous glucocorticoids have different roles in modulating endotoxin lethality in D-galactosamine-sensitized mice.

J C Gonzalez1, D C Johnson, D C Morrison, M A Freudenberg, C Galanos, R Silverstein.   

Abstract

Endotoxin sensitivity and dexamethasone protection have been assessed in mice that were adrenalectomized and also treated with D-galactosamine at the time of endotoxin challenge. Our data establish that adrenalectomy did not detectably alter the magnitude of the increased sensitivity induced by D-galactosamine alone. Furthermore, protection provided by acute exogenous glucocorticoid treatment was still demonstrable in these mice and was not influenced by chronic experimentally induced glucocorticoid deficiency. Our data confirm that the adrenalectomized mouse model of endotoxin lethality is characterized by increased sensitivity to endotoxin and establish that the magnitude of this sensitizing effect is more than 100-fold. We also show for the first time that adrenalectomy causes an appreciable kinetic shift in the endotoxic crisis and that dexamethasone, given at the time of endotoxin challenge, will significantly reverse the increased sensitivity to lethality. Our results indicate that the protective effects of corticosteroids may involve important chronic as well as acute responses. In particular, we conclude that endogenous glucocorticoid need not always increase host resistance to endotoxin, nor does such a circumstance eliminate the possibility for exogenous glucocorticoid-mediated protective effects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432617      PMCID: PMC302827          DOI: 10.1128/iai.61.3.970-974.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

Review 1.  Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death.

Authors:  K Decker; D Keppler
Journal:  Rev Physiol Biochem Pharmacol       Date:  1974       Impact factor: 5.545

2.  Leukotriene D4 mediates galactosamine/endotoxin-induced hepatitis in mice.

Authors:  A Wendel; G Tiegs
Journal:  Biochem Pharmacol       Date:  1987-06-15       Impact factor: 5.858

3.  Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages.

Authors:  M A Freudenberg; C Galanos
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

4.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

5.  Shock and tissue injury induced by recombinant human cachectin.

Authors:  K J Tracey; B Beutler; S F Lowry; J Merryweather; S Wolpe; I W Milsark; R J Hariri; T J Fahey; A Zentella; J D Albert
Journal:  Science       Date:  1986-10-24       Impact factor: 47.728

6.  Influence of endotoxin treatment on dexamethasone induction of hepatic phosphoenolpyruvate carboxykinase.

Authors:  R E McCallum; T W Seale; R D Stith
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

7.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

Authors:  B Beutler; N Krochin; I W Milsark; C Luedke; A Cerami
Journal:  Science       Date:  1986-05-23       Impact factor: 47.728

8.  EFFECTS OF BACTERIAL ENDOTOXINS ON METABOLISM. VII. ENZYME INDUCTION AND CORTISONE PROTECTION.

Authors:  L J BERRY; D S SMYTHE
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

9.  Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor.

Authors:  R Bertini; M Bianchi; P Ghezzi
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

10.  Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.

Authors:  V Lehmann; M A Freudenberg; C Galanos
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

View more
  6 in total

1.  Lipopolysaccharide-induced apoptosis in swine lymphocytes in vivo.

Authors:  M Norimatsu; T Ono; A Aoki; K Ohishi; T Takahashi; G Watanabe; K Taya; S Sasamoto; Y Tamura
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

2.  Differential host inflammatory responses to viable versus antibiotic-killed bacteria in experimental microbial sepsis.

Authors:  R Silverstein; J G Wood; Q Xue; M Norimatsu; D L Horn; D C Morrison
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

3.  Carrageenan primes leukocytes to enhance lipopolysaccharide-induced tumor necrosis factor alpha production.

Authors:  M Ogata; T Matsui; T Kita; A Shigematsu
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

4.  SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance.

Authors:  Lei Cai; Ailing Ji; Frederick C de Beer; Lisa R Tannock; Deneys R van der Westhuyzen
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

5.  Endogenous and exogenous glucocorticoids in experimental enterococcal infection.

Authors:  Christopher J Papasian; Nilofer Qureshi; David C Morrison
Journal:  Clin Vaccine Immunol       Date:  2006-03

6.  Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counterregulatory mechanism that restrains the immune response.

Authors:  M Zhang; T Caragine; H Wang; P S Cohen; G Botchkina; K Soda; M Bianchi; P Ulrich; A Cerami; B Sherry; K J Tracey
Journal:  J Exp Med       Date:  1997-05-19       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.